Monique Dail

Statistics

Publications

Citations

2.5K

H-Index

Active since

2002

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

AbbVie (United States)

University of California, San Francisco

University of Colorado Denver

University of Pennsylvania

Monique Dail is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and hematologic malignancy therapy.

ORCID

Publications per year

2002–2024

Publications

An Ephrin Mimetic Peptide That Selectively Targets the EphA2 Receptor

Mitchell Koolpe, Monique Dail, Elena B. Pasquale · Journal of Biological Chemistry · 2002 · 209 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

Venetoclax Plus Gilteritinib for <i>FLT3</i>-Mutated Relapsed/Refractory Acute Myeloid Leukemia

Naval Daver, Alexander E. Perl, Joseph Maly et al. · Journal of Clinical Oncology · 2022 · 187 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine

Keith W. Pratz, Brian A. Jonas, Vinod Pullarkat et al. · Journal of Clinical Oncology · 2021 · 170 citations · Full text

Medicine, Hematology, Oncology +14

Outcomes in Patients with Poor-Risk Cytogenetics with or without <i>TP53</i> Mutations Treated with Venetoclax and Azacitidine

Daniel A. Pollyea, Keith W. Pratz, Andrew H. Wei et al. · Clinical Cancer Research · 2022 · 145 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

EphB Receptor-binding Peptides Identified by Phage Display Enable Design of an Antagonist with Ephrin-like Affinity

Mitchell Koolpe, Rosemary Burgess, Monique Dail et al. · Journal of Biological Chemistry · 2005 · 143 citations · Full text

Medicine, Molecular Biology, Pharmacology +17

1–5 of 37